Intervention not reported
Vomiting · Patients with neurological conditions associated with rarer dementias
The intervention probably leads to higher vomiting (moderate certainty).
1 finding from 1 review
Intervention not reported
Cognitive function ‐ the Unified Huntington's Disease Rating Scale‐Verbal Fluency Test change UHDRS‐FAS1 · Huntington's disease
1 finding from 1 review
Intervention not reported
Cognitive function ‐ Verbal fluency test Verbal fluency test1 · Huntington's disease
1 finding from 1 review
Intervention not reported
Cognitive function ‐Symbol Digit Modalities Test SDMT1 · Huntington's disease
1 finding from 1 review
Intervention not reported
Cognitive function ‐ California Verbal Learning Test‐II trials 1‐5 CVLT‐II trials 1‐51 · Huntington's disease
1 finding from 1 review
Intervention not reported
Cognitive function ‐ California Verbal Learning Test‐II short‐delay recall CVLT‐II SD recall1 · Huntington's disease
1 finding from 1 review
Intervention not reported
Cognitive function ‐ California Verbal Learning Test‐II long‐delay recall CVLT‐II LD recall1 · Huntington's disease
1 finding from 1 review
Intervention not reported
Cognitive function ‐ California Verbal Learning Test‐II recognition task CVLT‐II recognition task1 · Huntington's disease
1 finding from 1 review
Improved muscle function various methods1 · people with myasthenia gravis
1 finding from 1 review
no estimate extracted
10 participants
Very low
Adverse events · people with myasthenia gravis
1 finding from 1 review
Change in impairment 1 to 14 days after the start of treatment ‐ not reported · people with myasthenia gravis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Global effect: 1a. Medium‐term ‐ Average end point score on various outcomes ‐ CGI‐severity (low = favourable) ( · schizophrenia
1 finding from 1 review
Intervention not reported
Leaving the study early ‐ Adverse event: Short‐term · schizophrenia
The intervention showed no clear difference in leaving the study early ‐ Adverse event: Short‐term; GRADE not reported.
1 finding from 1 review
Intervention not reported
Mental state: 1b. Average end point score on various outcomes‐PANSS (medium‐term) ‐ Medium‐term ‐ PANSS negative end point score (low = favourable) · schizophrenia
1 finding from 1 review
Intervention not reported
Mental state: 1b.Average end point score on various outcomes‐PANSS (medium‐term) ‐ Medium term ‐ PANSS general psychopathology end point score (low = favourable) · schizophrenia
1 finding from 1 review
Intervention not reported
Cognitive function: 3. Short‐term ‐ Average end point score on various subscales of WAIS III (high = favourable) ‐ Digit symbol score · schizophrenia
1 finding from 1 review
Intervention not reported
Cognitive function: 4. Short‐term ‐ Average end point score on various subscales of HVLT (high = favourable) ‐ Recognition · schizophrenia
1 finding from 1 review
Intervention not reported
Adverse event: 11a. Short‐term ‐ Average end point score on EPSEs scale (low = favourable) ‐ AIMS · schizophrenia
1 finding from 1 review